Rituxan articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/04/23 14:10
2014/04/23 14:10
1d
Biogen Idec Inc. (NASDAQ: BIIB) today reported first quarter 2014 results, including revenue of $2.1 billion, a 51% increase compared to the first quarter of 2013. The revenue growth year-over-year...
2014/04/23 14:10
2014/04/23 14:10
Latest videos
2014/04/23 10:27
2014/04/23 10:27
1d
... with stock prices in 12th paragraph. For more on drugmaker deals, see EXT7 ) April 23 (Bloomberg) -- Sitting just two miles apart on opposite banks of the Rhine river in Basel,...
2014/04/14 11:17
2014/04/14 11:17
10d
The global market is estimated to reach $2.0 billion by 2018 at a CAGR of more than 20% between 2013 and 2018. The biosimilar products market is segmented into recombinant non-glycosylated proteins,...
2014/04/07 21:44
2014/04/07 21:44
16d
The war on cancer is getting some potent reinforcements, including a potentially broad-spectrum new weapon and genetically engineered immune cells with improved cancer-fighting abilities, speakers...
2014/04/07 08:27
2014/04/07 08:27
17d
... to add diagnostics purchase in sixth paragraph.) April 7 (Bloomberg) -- Roche Holding AG will buy the rights to a drug meant to switch on genes that block cancer’s growth in a deal to be...
2014/04/03 15:08
2014/04/03 15:08
20d
The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal...
Xolair Soliris
MENTIONED
2014/04/23 14:10
2014/04/23 14:10
Latest from Twitter